Omvoh

Active Ingredient(s): Mirikizumab-mrkz
FDA Approved: * October 26, 2023
Pharm Company: * ELI LILLY AND CO
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Omvoh 20 mg/ml Intravenous Injection, Solution
NDC: 0002-7575
Labeler:
Eli Lilly and Company
Omvoh 100 mg/ml Subcutaneous Injection, Solution
NDC: 0002-8011
Labeler:
Eli Lilly and Company
Omvoh 100 mg/ml Subcutaneous Injection, Solution
NDC: 0002-8870
Labeler:
Eli Lilly and Company